Hedge funds' favorite stocks lag broader market -Goldman data

BOSTON, Nov 23 (Reuters) - Hedge fund managers' favorite stocks stumbled hard this year to post their worst returns since the financial crisis with health-care companies, such as Valeant Pharmaceuticals, leading the way lower, according to new data from Goldman Sachs.